Abstract

Astrocytes, which can be obtained from neural stem cells (NSCs) by adding serum and/or recombinant proteins in culture media or by passaging NSCs repeatedly, are expected to be applicable in regenerative medicine for the treatment of neurodegenerative diseases. However, astrocytes obtained using existing methods are costly and have poor quality. The stiffness of culture surfaces has been reported to affect astrocytic differentiation of adult NSCs. However, the influence of surface stiffness on astrocytic differentiation of embryonic NSCs has not yet been reported. In this study, we showed that astrocytic differentiation of embryonic NSCs was increased on soft surfaces (1 kPa and 12 kPa) compared with the NSCs on stiff surfaces (2.8 GPa) in serum-free condition. Furthermore, di-phosphorylated myosin regulatory light chain (PP-MRLC) was decreased in embryonic NSCs cultured on the soft surfaces than the cells on the stiff surfaces. Additionally, astrocytic differentiation of embryonic NSCs was induced by a Ras homolog associated kinase (ROCK) inhibitor, which decreased PP-MRLC in NSCs. These results suggest that decreasing the PP-MRLC of embryonic NSCs on soft surfaces or treating NSCs with a ROCK inhibitor is a good method to prepare astrocytes for application in regenerative medicine.

Highlights

  • Neural stem cells (NSCs) can differentiate into neurons and glia

  • QPCR analysis revealed that the mRNA expression of glial fibrillary acidic protein (GFAP) and mature astrocyte marker S100 calcium-binding protein B (S100B) was higher in the cells on soft surfaces than those on stiff surfaces (Fig. 2a–c)

  • We found that soft culture surfaces promote the differentiation of embryonic neural stem cells (NSCs) to astrocytes in serum-free conditions

Read more

Summary

Introduction

Neural stem cells (NSCs) can differentiate into neurons and glia. Among the glia, astrocytes are expected to be applicable in regenerative medicine for neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS) and spinal cord injury (SCI)[1,2,3,4]. Astrocytes can be obtained from NSCs by culturing NSCs in a medium containing serum and/or recombinant proteins to trigger astrocytic differentiation or by passaging NSCs r­ epeatedly[5,6,7,8]. These existing methods are not ideal for regenerative medicine applications. Y27632, a widely used ROCK inhibitor, reduced PP-MRLC in embryonic NSCs and promoted astrocytic differentiation of embryonic NSCs on stiff surfaces These results suggest that in serum-free conditions, culturing embryonic NSCs on soft surfaces or with Y27632 might be a suitable alternative to prepare astrocytes in regenerative medicine

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call